Status:
COMPLETED
Otago Exercises on the Risk of Falling in Prostatic Cancer Patients Receiving Androgen Deprivation Therapy
Lead Sponsor:
MTI University
Conditions:
Prostate
Eligibility:
MALE
50-75 years
Phase:
NA
Brief Summary
Androgen deprivation therapy (ADT) is a common treatment for older men with advanced prostate cancer (PCa) but is associated with numerous deleterious health effects that may accentuate age associated...
Detailed Description
Androgen deprivation therapy (ADT) is a common treatment for older men with advanced prostate cancer (PCa) but is associated with numerous deleterious health effects that may accentuate age associated...
Eligibility Criteria
Inclusion
- Men aged 50 years or older diagnosed with adenocarcinoma prostate cancer.
- Will initiate and receive continuous ADT (luteinizing hormone releasing hormone agonist (LHRH) or combination of LHRH and anti-androgen) for at least 6 months after recruitment.
- Report \> 1 fall in the past year OR have a score on one of two physical performance tests that is associated with increased fall risk (i.e., ≥ 12.0 s to complete the 3 m timed up and go (TUG)
- Willing to attend \>75% of intervention Otago exercises
Exclusion
- severe cardiac disease (New York Heart Association class III or greater), angina,
- uncontrolled hypertension (blood pressure \> 160/95 mmHg), moderate to severe aortic stenosis, acute illness or fever, uncontrolled atrial or ventricular dysrhythmias, uncontrolled sinus tachycardia (\> 120 beats per minute), third-degree atrioventricular heart block
- lower limb fracture within last 3 months , lower limb amputation
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2025
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT06605846
Start Date
September 23 2024
End Date
April 1 2025
Last Update
April 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MTI university
Multiple Locations, Egypt, 11511